Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Blood Clots Are Big Market For Biotech Medicines Co.
Investors.com
Wednesday, April 17, 2013 - 10:54am
tags:
blood clots, Medicines Company, Angiomax, Cleviprex, Recothrom, Argatroban
Lilly to acquire Alzheimer's imaging agents from Siemens
Reuters
Wednesday, April 17, 2013 - 10:52am
tags:
Alzheimer's disease, Siemenfs, imaging agents
Amarantus LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
Seeking Alpha
Wednesday, April 17, 2013 - 10:51am
tags:
LymPro, Amarantus BioSciences, Alzheimer's disease, Pfizer, Forest Labs, Eli Lilly
Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha
Wednesday, April 17, 2013 - 10:50am
tags:
Array Biopharma, Amgen, Novartis, AstraZeneca, selumetinib, MEK162, melanoma, non-small cell lung cancer
Abbott’s Profit Rose on Nutritional Product Sales
Bloomberg
Wednesday, April 17, 2013 - 10:48am
tags:
earnings, Abbott Laboratories
FDA Bans Generics of Purdue's Older OxyContin Painkiller
Bloomberg
Wednesday, April 17, 2013 - 10:46am
tags:
FDA, generics, oxycontin, Purdue, Impax Labs, Teva
Biotech Alkermes Poised To Swell On Pipeline Wins
Investors.com
Wednesday, April 17, 2013 - 10:44am
tags:
Alkermes
J&J Jury Urged to Award $5 Million for Failed Metal Hip
Bloomberg
Wednesday, April 17, 2013 - 10:43am
tags:
JNJ, hip implants, DePuy
Almirall, Forest report positive results in inhaler trial
Reuters
Tuesday, April 16, 2013 - 12:14pm
tags:
Almirall, Forest Labs, COPD, Genuair
FDA staff concerned about safety of Endo's testosterone injection
Reuters
Tuesday, April 16, 2013 - 12:12pm
tags:
Endo Health Solutions, FDA, testosterone, Aveed
FDA declines to approve new Allergan migraine drug
Reuters
Tuesday, April 16, 2013 - 12:06pm
tags:
FDA, migraines, Levadex, Allergan
Can These Biotechs Continue to Climb?
Motley Fool
Tuesday, April 16, 2013 - 12:04pm
tags:
Regeneron, NPS Pharmaceuticals
Does JAZZ Have Any Pizzazz Left?
Seeking Alpha
Tuesday, April 16, 2013 - 12:03pm
tags:
Jazz Pharmaceuticals
2 Views on Sarepta's FDA News
Motley Fool
Tuesday, April 16, 2013 - 12:02pm
tags:
FDA, Duchenne Muscular Dystrophy, Sarepta, eteplirsen
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tuesday, April 16, 2013 - 11:55am
tags:
sofosbuvir, Achillion, AbbVie, Bristol-Myers Squibb, Gilead, Merck, Idenix
Troubled Compounders: What FDA Knew And When It Knew
Pharmalot
Tuesday, April 16, 2013 - 11:42am
tags:
compounding pharmacies, FDA
Dismay at Sanofi stance on Alzheimer's research
Pharma Times, UK
Tuesday, April 16, 2013 - 11:41am
tags:
Sanofi, Alzheimer's disease, Chris Viehbacher
Sales Reps Overboard: AbbVie To Layoff Hundreds
Pharmalot
Tuesday, April 16, 2013 - 11:40am
tags:
drug reps, layoffs, AbbVie
Why We Expect The FDA To Approve Aveo's Tivozanib
Seeking Alpha
Tuesday, April 16, 2013 - 10:52am
tags:
FDA, tivozanib, Aveo Pharmaceutical, renal cell carcinoma
Drug Makers Use Safety Rule to Block Generics
NY Times, NY
Tuesday, April 16, 2013 - 10:50am
tags:
generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.